Klotho Neurosciences Inc. (KLTO)
Klotho Neurosciences Statistics
Share Statistics
Klotho Neurosciences has 32.49M shares outstanding. The number of shares has increased by null% in one year.
| 32.49M |
| n/a |
| n/a |
| n/a |
| n/a |
| 77,420 |
| 0.22% |
Short Selling Information
The latest short interest is 2.31M, so 7.12% of the outstanding shares have been sold short.
| 2.31M |
| 7.12% |
| 10.25% |
| 1 |
Valuation Ratios
The PE ratio is -1.52 and the forward PE ratio is null. Klotho Neurosciences's PEG ratio is 0.
| -1.52 |
| n/a |
| 0 |
| n/a |
| 7.88 |
| -3.04 |
| 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Klotho Neurosciences.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 0.13, with a Debt / Equity ratio of 0.23.
| 0.13 |
| 0.13 |
| 0.23 |
| -0.05 |
| -0.09 |
| -15.54 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-2,050,124 |
| 3 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.14, so Klotho Neurosciences's price volatility has been higher than the market average.
| 0.14 |
| n/a |
| 0.28 |
| 0.44 |
| 72.05 |
| 34,437,319 |
Balance Sheet
The company has 63.74K in cash and 271.75K in debt, giving a net cash position of -208.01K.
| 63.74K |
| 271.75K |
| -208.01K |
| -10.56M |
| 2.46M |
| -1.09M |
Cash Flow
In the last 12 months, operating cash flow was -2.95M and capital expenditures -123.5K, giving a free cash flow of -3.07M.
| -2.95M |
| -123.5K |
| -3.07M |
| -0.16 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
KLTO does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -10.54 |
| 3 |